Navigating the Novel Psychotropics.
作者信息
Dunlop Boadie W
机构信息
Department of Psychiatry and Behavioral Sciences and Mood and Anxiety Disorders Program, Emory University School of Medicine, Atlanta.
出版信息
Focus (Am Psychiatr Publ). 2021 Jan;19(1):1-2. doi: 10.1176/appi.focus.20200044. Epub 2021 Jan 25.
Abstract
摘要
相似文献
1
Navigating the Novel Psychotropics.探索新型精神药物
Focus (Am Psychiatr Publ). 2021 Jan;19(1):1-2. doi: 10.1176/appi.focus.20200044. Epub 2021 Jan 25.
2
Developmental perspectives in pediatric psychopharmacology.儿科精神药理学的发展视角
Psychopharmacol Bull. 1995;31(1):75-81.
3
Psychopharmacology in psychodermatology.心理皮肤病学中的精神药理学。
J Cutan Med Surg. 2008 Nov-Dec;12(6):255-67. doi: 10.2310/7750.2008.07062.
4
[Drugs in the Developmental Stage (Psychotropics)].[处于研发阶段的药物（精神药物）]
Brain Nerve. 2023 May;75(5):437-440. doi: 10.11477/mf.1416202356.
5
Neuroscience-based nomenclature of psychotropics: Progress report.基于神经科学的精神药物命名法：进展报告。
Eur Neuropsychopharmacol. 2022 Apr;57:36-38. doi: 10.1016/j.euroneuro.2022.01.002. Epub 2022 Jan 22.
6
Competent psychopharmacology.胜任的精神药理学。
Can J Psychiatry. 2014 Aug;59(8):406-11. doi: 10.1177/070674371405900802.
7
Proceedings of the 2nd Croatian Congress on Side Effects of Psychotropics. March 11-14, 2010. Rovinj, Croatia.第二届克罗地亚精神药物副作用大会会议记录。2010年3月11日至14日。克罗地亚罗维尼
Psychiatr Danub. 2010 Mar;22(1):68-142.
8
Psychiatric diagnosis and clinical trial completion rates: analysis of the FDA SBA reports.精神科诊断与临床试验完成率：对美国食品药品监督管理局小企业援助报告的分析
Neuropsychopharmacology. 2007 Nov;32(11):2422-30. doi: 10.1038/sj.npp.1301361. Epub 2007 Feb 21.
9
Innovations in Psychopharmacology Education in U.S. Psychiatric Residency Programs.美国精神科住院医师培训项目中的精神药理学教育创新。
Focus (Am Psychiatr Publ). 2021 Jan;19(1):46-49. doi: 10.1176/appi.focus.20200037. Epub 2021 Jan 25.
10
[Psychotropics].[精神药物]
AMB Rev Assoc Med Bras. 1969 Mar;15(3):141-8.
本文引用的文献
1
Moving on With Monoamine Oxidase Inhibitors.继续探讨单胺氧化酶抑制剂
Focus (Am Psychiatr Publ). 2021 Jan;19(1):50-52. doi: 10.1176/appi.focus.20200046. Epub 2021 Jan 25.
2
Innovations in Psychopharmacology Education in U.S. Psychiatric Residency Programs.美国精神科住院医师培训项目中的精神药理学教育创新。
Focus (Am Psychiatr Publ). 2021 Jan;19(1):46-49. doi: 10.1176/appi.focus.20200037. Epub 2021 Jan 25.
3
Treatment of Hypoactive Sexual Desire Disorder Among Women: General Considerations and Pharmacological Options.女性性欲减退障碍的治疗：一般考量与药物治疗选择
Focus (Am Psychiatr Publ). 2021 Jan;19(1):39-45. doi: 10.1176/appi.focus.20200039. Epub 2021 Jan 25.
4
Novel Formulations of ADHD Medications: Stimulant Selection and Management.注意力缺陷多动障碍药物的新型制剂：兴奋剂的选择与管理
Focus (Am Psychiatr Publ). 2021 Jan;19(1):31-38. doi: 10.1176/appi.focus.20200032. Epub 2021 Jan 25.
5
Increasing Psychiatrists' Role in Addressing the Cardiovascular Health of Patients With Severe Mental Illness.增强精神科医生在解决重症精神疾病患者心血管健康问题中的作用。
Focus (Am Psychiatr Publ). 2021 Jan;19(1):24-30. doi: 10.1176/appi.focus.20200036. Epub 2021 Jan 25.
6
Tardive Dyskinesia: Spotlight on Current Approaches to Treatment.迟发性运动障碍：当前治疗方法聚焦
Focus (Am Psychiatr Publ). 2021 Jan;19(1):14-23. doi: 10.1176/appi.focus.20200038. Epub 2021 Jan 25.
7
Contrasting Typical and Atypical Antipsychotic Drugs.对比典型与非典型抗精神病药物
Focus (Am Psychiatr Publ). 2021 Jan;19(1):3-13. doi: 10.1176/appi.focus.20200051. Epub 2021 Jan 25.
8
Sustained-release, extended-release, and other time-release formulations in neuropsychiatry.神经精神病学中的缓释、长效释放及其他定时释放制剂。
J Clin Psychiatry. 2015 Aug;76(8):e995-9. doi: 10.4088/JCP.15f10219.
9
Is pharma running out of brainy ideas?制药行业是否已想不出聪明的点子了？
Science. 2010 Jul 30;329(5991):502-4. doi: 10.1126/science.329.5991.502.
10
Effective half-life in clinical pharmacology.临床药理学中的有效半衰期。
J Clin Pharmacol. 1995 Aug;35(8):763-6. doi: 10.1002/j.1552-4604.1995.tb04117.x.
Zotero 插件